Articles Authored by Madeleine Johnson

Nov 07, 2019

OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy

Premium

The firm is also targeting a new market for oral fluid-based tests for drugs of abuse, projecting future growth due to new federal regulations.

Nov 04, 2019

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Premium

A San Jose, California-based company appears to be the first in the US to routinely offer nanopore sequencing as part of a testing lab service.

Oct 31, 2019

Quidel Touts Product Pipeline Despite Revenue Headwinds

Premium

The firm plans to launch 10 new products next year, but analysts were cautious about Quidel's prospects moving forward.

Oct 29, 2019

Inexpensive LAMP-Based Schistosome Tests Could Help Eradication Efforts

Premium

Isothermal molecular assays to diagnose a parasitic infection that afflicts approximately 300 million people are moving closer to commercialization.

Oct 24, 2019

Large-Scale Unbiased Antibody Capture Method Links Enteroviruses to Acute Flaccid Myelitis

Premium

After years of frustration, researchers can now more definitively link a polio-like syndrome to prior infection with two common respiratory viruses.

Sep 30, 2019

Q&A: BARDA Director Rick Bright Discusses New Programs, Focus on Diagnostics

Premium

The director of the Biomedical Advanced Research and Development Authority has launched two new funding programs in the past three years.

Sep 27, 2019

Accelerate Diagnostics Banking on New Outcomes Data, Experienced COO to Drive Sales Growth

Premium

New outcomes data shows that the firm's test can help clinicians optimize antibiotic prescribing, but investment analysts have had mixed reactions.

Sep 13, 2019

Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx

Premium

Based in Warsaw, Poland, the technology was inspired by "ultra-fast" PCR methods from the Wittwer group and Scope plans to launch tests for MRSA and C. diff.

Sep 13, 2019

BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth

Premium

While the news of the BARDA contract drove a surge in T2's stock price, it was last month's NTAP decision that has company officials and analysts encouraged.

Sep 06, 2019

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

Premium

New resistance tests for Mycoplasma genitalium and gonorrhea could help stave off superbugs, but guidelines and economic factors may hinder adoption.

Menu

Articles Authored by Madeleine Johnson

OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Quidel Touts Product Pipeline Despite Revenue Headwinds

Inexpensive LAMP-Based Schistosome Tests Could Help Eradication Efforts

Large-Scale Unbiased Antibody Capture Method Links Enteroviruses to Acute Flaccid Myelitis

Q&A: BARDA Director Rick Bright Discusses New Programs, Focus on Diagnostics

Accelerate Diagnostics Banking on New Outcomes Data, Experienced COO to Drive Sales Growth

Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx

BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

Breaking News

NeoGenomics Q4 Revenue Up 40 Percent

Co-Diagnostics Announces $4.2M Direct Offering

Oxford Nanopore Licenses NuProbe Sample Prep Technology

Microbiome Composition Predicts Clinical Outcome Among Stem Cell Transplant Patients

NanoString Technologies Q4 Revenues Up 23 Percent

Natera Q4 Revenues Rise 24 Percent

The Scan

Two Red Panda Species

Nature Papers Explore Epigenetic Factors in Aging, Gene Loss in Animal Kingdom

Walking Around

For Better Identification

Sponsorships

Menu

Articles Authored by Madeleine Johnson

Pages

Sponsorships